38340211000001108: Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd)
\UK product\Virtual medicinal product\Product containing precisely ethinylestradiol 30 microgram and gestodene 75 microgram/1 each conventional release oral tablet\Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd)
\UK product\Virtual therapeutic moiety\Ethinylestradiol + Gestodene\Product containing only ethinylestradiol and gestodene in oral dose form (medicinal product form)\Product containing precisely ethinylestradiol 30 microgram and gestodene 75 microgram/1 each conventional release oral tablet\Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd)
\UK product\Virtual therapeutic moiety\Ethinylestradiol + Gestodene\Product containing precisely ethinylestradiol 30 microgram and gestodene 75 microgram/1 each conventional release oral tablet\Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd)
\UK product\Trade family\Akizza\Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing hormone\Product containing progesterone receptor agonist (product)\Product containing gestodene\Product containing ethinylestradiol and gestodene\Ethinylestradiol + Gestodene\Product containing only ethinylestradiol and gestodene in oral dose form (medicinal product form)\Product containing precisely ethinylestradiol 30 microgram and gestodene 75 microgram/1 each conventional release oral tablet\Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing hormone\Product containing progesterone receptor agonist (product)\Product containing gestodene\Product containing ethinylestradiol and gestodene\Ethinylestradiol + Gestodene\Product containing precisely ethinylestradiol 30 microgram and gestodene 75 microgram/1 each conventional release oral tablet\Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing hormone\Product containing progesterone receptor agonist (product)\Product containing gestodene\Product containing ethinylestradiol and gestodene\Product containing ethinylestradiol and gestodene in oral dose form (medicinal product form)\Product containing only ethinylestradiol and gestodene in oral dose form (medicinal product form)\Product containing precisely ethinylestradiol 30 microgram and gestodene 75 microgram/1 each conventional release oral tablet\Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing hormone\Product containing estrogen receptor agonist (product)\Product containing ethinylestradiol\Product containing ethinylestradiol in oral dose form (medicinal product form)\Product containing ethinylestradiol and gestodene in oral dose form (medicinal product form)\Product containing only ethinylestradiol and gestodene in oral dose form (medicinal product form)\Product containing precisely ethinylestradiol 30 microgram and gestodene 75 microgram/1 each conventional release oral tablet\Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing hormone\Product containing estrogen receptor agonist (product)\Product containing ethinylestradiol\Product containing ethinylestradiol and gestodene\Ethinylestradiol + Gestodene\Product containing only ethinylestradiol and gestodene in oral dose form (medicinal product form)\Product containing precisely ethinylestradiol 30 microgram and gestodene 75 microgram/1 each conventional release oral tablet\Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing hormone\Product containing estrogen receptor agonist (product)\Product containing ethinylestradiol\Product containing ethinylestradiol and gestodene\Ethinylestradiol + Gestodene\Product containing precisely ethinylestradiol 30 microgram and gestodene 75 microgram/1 each conventional release oral tablet\Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing hormone\Product containing estrogen receptor agonist (product)\Product containing ethinylestradiol\Product containing ethinylestradiol and gestodene\Product containing ethinylestradiol and gestodene in oral dose form (medicinal product form)\Product containing only ethinylestradiol and gestodene in oral dose form (medicinal product form)\Product containing precisely ethinylestradiol 30 microgram and gestodene 75 microgram/1 each conventional release oral tablet\Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing steroid\Product containing gestodene\Product containing ethinylestradiol and gestodene\Ethinylestradiol + Gestodene\Product containing only ethinylestradiol and gestodene in oral dose form (medicinal product form)\Product containing precisely ethinylestradiol 30 microgram and gestodene 75 microgram/1 each conventional release oral tablet\Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing steroid\Product containing gestodene\Product containing ethinylestradiol and gestodene\Ethinylestradiol + Gestodene\Product containing precisely ethinylestradiol 30 microgram and gestodene 75 microgram/1 each conventional release oral tablet\Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing steroid\Product containing gestodene\Product containing ethinylestradiol and gestodene\Product containing ethinylestradiol and gestodene in oral dose form (medicinal product form)\Product containing only ethinylestradiol and gestodene in oral dose form (medicinal product form)\Product containing precisely ethinylestradiol 30 microgram and gestodene 75 microgram/1 each conventional release oral tablet\Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing steroid\Product containing ethinylestradiol\Product containing ethinylestradiol in oral dose form (medicinal product form)\Product containing ethinylestradiol and gestodene in oral dose form (medicinal product form)\Product containing only ethinylestradiol and gestodene in oral dose form (medicinal product form)\Product containing precisely ethinylestradiol 30 microgram and gestodene 75 microgram/1 each conventional release oral tablet\Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing steroid\Product containing ethinylestradiol\Product containing ethinylestradiol and gestodene\Ethinylestradiol + Gestodene\Product containing only ethinylestradiol and gestodene in oral dose form (medicinal product form)\Product containing precisely ethinylestradiol 30 microgram and gestodene 75 microgram/1 each conventional release oral tablet\Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing steroid\Product containing ethinylestradiol\Product containing ethinylestradiol and gestodene\Ethinylestradiol + Gestodene\Product containing precisely ethinylestradiol 30 microgram and gestodene 75 microgram/1 each conventional release oral tablet\Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing steroid\Product containing ethinylestradiol\Product containing ethinylestradiol and gestodene\Product containing ethinylestradiol and gestodene in oral dose form (medicinal product form)\Product containing only ethinylestradiol and gestodene in oral dose form (medicinal product form)\Product containing precisely ethinylestradiol 30 microgram and gestodene 75 microgram/1 each conventional release oral tablet\Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as contraceptive (product)\Product containing ethinylestradiol and gestodene\Ethinylestradiol + Gestodene\Product containing only ethinylestradiol and gestodene in oral dose form (medicinal product form)\Product containing precisely ethinylestradiol 30 microgram and gestodene 75 microgram/1 each conventional release oral tablet\Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as contraceptive (product)\Product containing ethinylestradiol and gestodene\Ethinylestradiol + Gestodene\Product containing precisely ethinylestradiol 30 microgram and gestodene 75 microgram/1 each conventional release oral tablet\Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as contraceptive (product)\Product containing ethinylestradiol and gestodene\Product containing ethinylestradiol and gestodene in oral dose form (medicinal product form)\Product containing only ethinylestradiol and gestodene in oral dose form (medicinal product form)\Product containing precisely ethinylestradiol 30 microgram and gestodene 75 microgram/1 each conventional release oral tablet\Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing ethinylestradiol in oral dose form (medicinal product form)\Product containing ethinylestradiol and gestodene in oral dose form (medicinal product form)\Product containing only ethinylestradiol and gestodene in oral dose form (medicinal product form)\Product containing precisely ethinylestradiol 30 microgram and gestodene 75 microgram/1 each conventional release oral tablet\Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 13-May 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

1317461000001112 Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1317471000001119 Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd)	Is a	Product containing precisely ethinylestradiol 30 microgram and gestodene 75 microgram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd)	Has excipient	Lactose	false	Inferred relationship	Existential restriction modifier
Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd)	Is a	Akizza	true	Inferred relationship	Existential restriction modifier
Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd)	Has specific active ingredient	Ethinylestradiol	true	Inferred relationship	Existential restriction modifier
Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd)	Has specific active ingredient	Gestodene	true	Inferred relationship	Existential restriction modifier
Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd) 63 tablet 3 x 21 tablets	Has AMP	True	Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1317461000001112	Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
1317471000001119	Akizza 75microgram/30microgram tablets (Morningside Healthcare Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module